Word on the street is Ozempic might become more affordable in Canada next year when generics hit the market.
The reason for the potential price drop? Apparently, there was a missed patent maintenance payment:
"Novo Nordisk is set to lose its patent protection for both Ozempic and Wegovy in Canada due to a lapse in patent maintenance. The non-payment of a maintenance fee, said to be around $450 CAD, back in 2019 has led to the patent's expiration. This opens the door for generic manufacturers to legally produce and sell semaglutide, the active ingredient in Ozempic, potentially leading to much lower prices."
I hear there are three or four companies gearing up to produce it. If there's enough competition, we could see prices plummet from $400 a month to maybe $100 or even less.
The reason for the potential price drop? Apparently, there was a missed patent maintenance payment:
"Novo Nordisk is set to lose its patent protection for both Ozempic and Wegovy in Canada due to a lapse in patent maintenance. The non-payment of a maintenance fee, said to be around $450 CAD, back in 2019 has led to the patent's expiration. This opens the door for generic manufacturers to legally produce and sell semaglutide, the active ingredient in Ozempic, potentially leading to much lower prices."
I hear there are three or four companies gearing up to produce it. If there's enough competition, we could see prices plummet from $400 a month to maybe $100 or even less.